NYSE:XAN - Exantas Capital Stock Price, Forecast & News

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

Exantas Capital declared a quarterly dividend on Friday, December 13th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.275 per share on Tuesday, January 28th. This represents a $1.10 annualized dividend and a yield of 9.60%. The ex-dividend date of this dividend is Monday, December 30th. This is an increase from Exantas Capital's previous quarterly dividend of $0.25. View Exantas Capital's Dividend History.

Exantas Capital Corp (NYSE:XAN) posted its quarterly earnings data on Tuesday, October, 30th. The company reported $0.24 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.04. The company earned $14.51 million during the quarter, compared to the consensus estimate of $14.60 million. Exantas Capital had a return on equity of 7.39% and a net margin of 63.39%. View Exantas Capital's Earnings History.

Exantas Capital is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Exantas Capital.

Exantas Capital will be holding an earnings conference call on Tuesday, March 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

1 Wall Street analysts have issued twelve-month price objectives for Exantas Capital's stock. Their forecasts range from $11.54 to $11.54. On average, they expect Exantas Capital's share price to reach $11.54 in the next year. This suggests a possible upside of 0.7% from the stock's current price. View Analyst Price Targets for Exantas Capital.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exantas Capital.

News headlines about XAN stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Exantas Capital earned a news impact score of -4.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the near future. View News Stories for Exantas Capital.

Some companies that are related to Exantas Capital include Monmouth R.E. Inv. (MNR), Kite Realty Group Trust (KRG), ARBOR RLTY TR I/SH (ABR), Industrial Logistics Properties Trust (ILPT), Independence Realty Trust (IRT), American Finance Trust (AFIN), KKR Real Estate Finance Trust (KREF), istar (STAR), NexPoint Residential Trust (NXRT), Tanger Factory Outlet Centers (SKT), ARMOUR Residential REIT (ARR), Saul Centers (BFS), Brookfield Property Reit (BPR), Community Healthcare Trust (CHCT) and RPT Realty (RPT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include Monroe Capital (MRCC), Prospect Capital (PSEC), Colony Capital (CLNY), Mplx (MPLX), Ashford Hospitality Trust (AHT), Enterprise Products Partners (EPD), Hercules Capital (HTGC), New Residential Investment (NRZ), Blackrock Capital Investment (BKCC) and CHIMERA INVT CO/SH NEW (CIM).

Exantas Capital's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Kennedy Capital Management Inc. (3.21%), State Street Corp (2.12%), Acadian Asset Management LLC (1.22%), Ancora Advisors LLC (1.17%), LSV Asset Management (0.89%) and Orinda Asset Management LLC (0.72%). View Institutional Ownership Trends for Exantas Capital.

XAN stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Ancora Advisors LLC, Sei Investments Co., Prudential Financial Inc., Citigroup Inc., Oxford Asset Management LLP, Chicago Equity Partners LLC and UBS Asset Management Americas Inc.. View Insider Buying and Selling for Exantas Capital.

XAN stock was acquired by a variety of institutional investors in the last quarter, including Orinda Asset Management LLC, LSV Asset Management, Marshall Wace LLP, Martingale Asset Management L P, Colony Capital Inc., Goldman Sachs Group Inc., State Street Corp and Bessemer Group Inc.. View Insider Buying and Selling for Exantas Capital.

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of XAN stock can currently be purchased for approximately $11.46.

Exantas Capital has a market capitalization of $365.36 million and generates $55.28 million in revenue each year. The company earns $27.43 million in net income (profit) each year or $0.71 on an earnings per share basis. View Additional Information About Exantas Capital.

The official website for Exantas Capital is http://www.exantas.com/.

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]